Offices of Drug Evaluation Deputy Directors
FDA has named deputies for each of its five drug review offices: Division of Anti-viral Drug Products' Rachel Berman, MD, (ODE I); Center for Devices & Radiologic Health Mammography Quality & Radiation Programs Division Deputy Director Florence Houn, MD, (ODE II); Medical Imaging & Radiopharmaceutical Drug Products Division Deputy Director Victor Raczkowski, MD, (ODE III); Reproductive & Urologic Drug Products Division Medical Officer Sandra Kweder, MD, (ODE IV); and Oncology Drug Products Division Director Robert Delap, MD, (ODE V)
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth